BMT CTN Protocol #0302, Initial System Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, MMF, Denileukin Diftitox, and Pentostatin in combinati
|Effective start/end date||5/3/05 → 8/31/06|
- National Marrow Donor Program
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.